XML 21 R6.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
OPERATING ACTIVITIES:    
Consolidated net loss $ (20,247,621) $ (7,255,706)
Adjustments to reconcile net income to net cash used in operating activities:    
Depreciation and amortization 2,953,629 1,462,492
Impairment loss 11,138,830
Bad debt expense 1,162,007
Forgiveness of notes payable (130,429) (90,711)
Common stock options issued for services 1,472,888 1,585,000
Common stock issued for services 438,004
Stock-based compensation 2,606,703 446,112
Unrealized loss- marketable securities 578,464 1,094,054
Gain on disposal of asset (2,456) (87,044)
Deferred income taxes (4,437,491) (1,051,007)
Changes in operating assets and liabilities:    
Accounts receivable 2,613,278 6,890
Prepaid expenses 59,900
Inventory 162,148
Other assets (80,220) 13,807
Right of use assets- finance leases 349,253  
Right of use assets- operating leases (1,216,765) 218,513
Operating lease liabilities 1,216,765 (218,513)
Financing lease liabilities (429,578)
Accounts payable and accrued expenses (3,408,157) 38,128
Interest on notes receivable (23,725) (3,313)
Interest on notes payable 1,519,281 501,598
Net cash used in operating activities (4,143,296) (2,901,696)
INVESTING ACTIVITIES:    
Proceeds from notes receivable 55,953
Payment on costs of patents (13,366)
Acquisition of assets 96,467
Purchase of a technology license (265,000)
Proceeds from disposal of equipment 6,000
Purchase of equipment (2,491,175) (4,236,276)
Net cash used in investing activities (2,332,755) (4,514,642)
FINANCING ACTIVITIES:    
Payment of long-term debt (7,735)
Proceeds from loans and notes payable 3,640,046 9,135,984
Proceeds from sale of common stock 6,240,000
Payment of notes payable (853,230) (562,046)
Distributions to noncontrolling interest (861,691) (55,050)
Net cash provided by financing activities 8,165,125 8,511,153
Net increase (decrease) in cash and cash equivalents 1,689,074 1,094,815
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD 1,493,719 398,904
CASH AND CASH EQUIVALENTS, END OF PERIOD 3,182,793 1,493,719
Cash paid during the year for:    
Interest 1,205,426 390,843
Income taxes
Noncash transactions:    
Conversion of Series A, B, B-1, and C-1 Preferred Stock to Common Stock 1,200,000 9,467,604
Common stock issued for a reduction in liabilities 1,144,992 495,799
Conversion of note receivable to equity investment 81,768
Noncontrolling interest issued for a reduction in liabilities 4,865,000 5,504,950
Preferred stock Series C-1 issued for a reduction in liabilities 64,950
Common stock issued for the purchase of a license 225,000
Capitalized interest on construction in process $ 1,614,697
Dividend paid in Series B-1 Preferred Stock 42,196
Common stock and note payable issued in the acquisition of Silver Fuels Delhi, LLC and White Claw Colorado City, LLC $ 32,951,939
Sale of marketable securities for note receivable 860,491
Accounts payable on purchase of equipment $ 259,846 $ 700,000